Steno Diabetes Center and the University of Copenhagen strengthen diabetes care and research with new professorship – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Health > News > Professorship

19 June 2015

Steno Diabetes Center and the University of Copenhagen strengthen diabetes care and research with new professorship

Professorship

A new, five-year professorship in human metabolism between Steno Diabetes Center and the University of Copenhagen will strengthen collaboration and research within diabetes.

John Nolan, head of Steno Diabetes Center, has been appointed Professor in Human Metabolism at the University of Copenhagen. During the next five years, he will work closely with the researchers at the university to increase the synergy between basic diabetes research and clinical care.

“As the largest diabetes specialist centre of its kind in the Nordic region, Steno Diabetes Center has the ideal clinical environment to support research of diabetes at all stages. We’re very pleased to continue our collaboration with the University of Copenhagen and to facilitate an even stronger platform for research, education and clinical care”, says John Nolan. “We also hope that the agreement will provide new opportunities for students with a special interest in diabetes research and care to come to Steno as part of their rotation”.     

”We are delighted to welcome John Nolan to the University of Copenhagen and are looking forward to benefit from his strong knowledge and experience within the area. Together we have the potential to reach new milestones within diabetes research, education, clinical care and health prevention and we are looking forward to develop the area in close collaboration for the benefit of the patients”, says Dean Ulla Wewer from the Faculty of Health and Medical Science at the University of Copenhagen.

John Nolan has a longstanding career within translational diabetes research and is Professor and Fellow at Trinity College in Dublin, Ireland. Since 2011 he has been the head of Steno Diabetes Center and for the next five years he will spend 20% of his time at the University of Copenhagen.

Steno Diabetes Center has more than 80 years of experience within diabetes care and research. The center is a not-for-profit organization owned by Novo Nordisk A/S and is working in partnership with Denmark’s health care system. Every year, more than 5.500 Danish patients with diabetes are being treated at the Steno clinic.

For more information visit steno.dk, Twitter, LinkedIn

Contact
Steno Diabetes Center, Marie Vedel Kessing
E-Mail: mvke@steno.dk
Mobile: +45 30 79 05 57

UCPH, Kristine Snedker
E-Mail: kristine.snedker@sund.ku.dk
Mobile: +45 23 64 88 42